ICM
VRN

Invenomic Capital Management’s Veren VRN Stock Holding History

Invenomic Capital Management’s Portfolio VRN Stock Details VRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,993,031
Closed -$10.2M – 209
2024
Q4 		$10.2M Buy
1,993,031
+453,672
+29% +$2.49M 0.49% 61
2024
Q3 		$9.47M Buy
1,539,359
+662,628
+76% +$4.74M 0.52% 65
2024
Q2 		$6.9M Sell
876,731
-1,219,195
-58% -$10.3M 0.34% 87
2024
Q1 		$17.2M Buy
2,095,926
+66,558
+3% +$466K 0.91% 39
2023
Q4 		$14.1M Sell
2,029,368
-980,912
-33% -$7.24M 0.64% 54
2023
Q3 		$25M Buy
3,010,280
+680,148
+29% +$5.42M 1.05% 26
2023
Q2 		$15.7M Sell
2,330,132
-155,171
-6% -$1.08M 0.79% 41
2023
Q1 		$17.5M Buy
2,485,303
+62,933
+3% +$436K 0.99% 36
2022
Q4 		$17.3M Sell
2,422,370
-729,125
-23% -$5.41M 1.18% 23
2022
Q3 		$19.4M Sell
3,151,495
-89,229
-3% -$637K 1.67% 14
2022
Q2 		$23.1M Buy
3,240,724
+2,377,392
+275% +$18.6M 1.64% 11
2022
Q1 		$4.96M Buy
863,332
+183,762
+27% +$1.24M 0.53% 61
2021
Q4 		$3.63M Buy
+679,570
New +$3.31M 0.78% 50

Other funds holding VRN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
ECA
Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
NP
Ninepoint Partners Toronto, Ontario, Canada $904M AUM 39.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invenomic Capital Management's VRN Position: Q1 2025 in Review

Invenomic Capital Management sold out of Veren (VRN) in Q1 2025, closing a stake of 1,993,031 shares — an estimated $10.2M sold.

Invenomic Capital Management first reported a position in VRN in Q4 2021 and held it in 13 quarters. The position peaked at $25M in Q3 2023. 200 funds tracked by Wall St. Rank hold VRN as of Q1 2025.

  • Invenomic Capital Management reported no remaining Veren position as of Q1 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 1,993,031 Veren shares in Q1 2025, an estimated $10.2M.
  • Invenomic Capital Management first reported a position in Veren in Q4 2021 and held it in 13 quarters.
  • Invenomic Capital Management's Veren position peaked at $25M in Q3 2023.
  • 200 funds tracked by Wall St. Rank held Veren as of Q1 2025.

Based on Invenomic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.